Addex Therapeutics Ltd (SWX:ADXN)

Addex Therapeutics Revenue

In the year 2025, Addex Therapeutics had annual revenue of 172.86K CHF, down -57.84%. Addex Therapeutics had revenue of 15.83K in the quarter ending December 31, 2025, with 949.73% growth.

• Revenue: 172.86K
• Revenue Growth: -57.84%
• P/S Ratio: 30.32
• Revenue / Employee: 86.50K
• Employees: 2
• Market Cap: 5.25M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	172.86K	-237.18K	-57.84%
Dec 31, 2024	410.04K	-1.21M	-74.64%
Dec 31, 2023	1.62M	172.23K	11.92%
Dec 31, 2022	1.44M	-1.71M	-54.18%
Dec 31, 2021	3.15M	-725.83K	-18.71%
Dec 31, 2020	3.88M	1.05M	36.89%
Dec 31, 2019	2.83M	-3.87M	-57.72%
Dec 31, 2018	6.70M	6.20M	1,240.82%
Dec 31, 2017	499.89K	373.24K	294.70%
Dec 31, 2016	126.65K	-348.97K	-73.37%
Dec 31, 2015	475.63K	-	-

Data Source: Fiscal.ai Last updated: Dec 31, 2025

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 8, 2026

Data Sources Report a data error